Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in RA Patients with Hepatitis B
NCT02053727Withdrawn
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2014
- Primary completion
- Jun 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised, double-blind trial in rheumatoid arthritis (RA) comparing Abatacept Arm with Placebo Arm (2 arms). Primary endpoints: Number of Participants with Serious Adverse Events and Number of Subjects with Hepatitis B Reactivation. Planned start Jul 2014; status: withdrawn.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02053727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053727.